PANews reported on August 15th that IVD Medical Holding Limited, a Hong Kong-listed company, plans to seek approval at a special general meeting of shareholders to authorize the board of directors to purchase cryptocurrencies, primarily Ethereum (ETH), for up to HK$3 billion over the next 36 months. The company stated that this move aims to strengthen its ETH reserves and accelerate the development of the ivd.xyz exchange ecosystem. The relevant cryptocurrencies will be purchased through regulated platforms such as HashKey Exchange, with funds sourced from the company's idle cash and potential fundraising. The announcement emphasized that a single premium will not exceed 10%, and a dedicated risk management team has been established.